 |
 |
 |
|
- Soluble CD163 is a biomarker for macrophage activity, inflammation, CVD and MS.
- sCD163 is very useful as a biomarker of macrophage activation in various inflammatory diseases, such as macrophage activation syndrome, sepsis, and liver disease. (Møller HJ. Soluble CD163. Scand J Clin Lab Invest. 2012 Feb;72(1):1-13)
Citations for Human CD163 ELISA Kit SK00694-01:
- PLoS One. 2014; 9(6): e98989. Published online 2014 Jun 4.
- Eleanor M. P. Wilson., et al. Monocyte-Activation Phenotypes Are Associated With Biomarkers of Inflammation and Coagulation in Chronic HIV Infection. The Journal of Infectious Diseases, 2014(210)Pages 1396–1406
- Min D, et al. Monocyte CD163 is altered in association with diabetic complications: possible protective role. J Leukoc Biol. 2016 Dec;100(6):1375-1383
- A. CINKAJZLOVÁ, et al. An Alternatively Activated Macrophage Marker CD163 in Severely Obese Patients: the Influence of Very Low-Calorie Diet and Bariatric Surgery. Physiol. Res. 66: 641-652, 2017
- Sun, Houchao et al. “Circulating Soluble CD163: A Potential Predictor for the Functional Outcome of Acute Ischemic Stroke.” Frontiers in neurology vol. 12 740420. 14 Dec. 2021, doi:10.3389/fneur.2021.740420
- Nielsen MC, et al. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease. Scand J Gastroenterol. 2020 May;55(5):588-596.
Citations for Human CD163 ELISA Kit SK00694-01  References related to MS: - Semnani-Azad Z, Connelly PW, Johnston LW, et al. The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function. J Clin Endocrinol Metab. 2020;105(3):e285-e294. doi:10.1210/clinem/dgz166
- Sherman KE, et al. Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis. Open Forum Infect Dis. 2021 Apr 22;8(6):ofab203. doi: 10.1093/ofid/ofab203.
|
|
|
 |
|
 |
|